Compare Alibaba Group (BABA) vs Tilray Brands Inc (TLRY) Price & Performance

Alibaba GroupTrade

Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Alibaba Group vs Tilray Brands Inc — how do they compare? Alibaba Group trades at $116.79 (market cap $270.95B), while Tilray Brands Inc trades at $4.37 (market cap $540.74M). The key difference: Alibaba Group is far larger — about 501.1× Tilray Brands Inc's market cap, and Alibaba Group pays a 0.93% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

	BABA	TLRY
Market Cap	$270.95B	$540.74M
Volume	18,069,938	—
Sector	Consumer Cyclical	Health
52-Week High	$189.34	$21.00
52-Week Low	$94.83	$4.31
Enterprise Value	$265.77B	$637.89M
Dividend Yield	0.93%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alibaba Group

Alibaba (BABA) trades at $112.35, up 0.02% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings misses contrast with robust fundamentals: revenue grew to $996.35B in 2025, net income margin expanded to 13.05%, and valuation ratios like P/E of 17.36 appear reasonable. The stock faces headwinds from securities investigations but benefits from AI-driven optimism in cloud growth.

Outlook remains positive given Wall Street's $195 price target and 86% buy ratings, though risks include legal overhangs and earnings volatility. AI and cloud initiatives offer growth catalysts, but investors should monitor regulatory developments and quarterly execution against expectations.

Tilray Brands Inc

TLRY trades at $4.46, up 0.9% on the day, amid a bearish technical signal and mixed earnings history. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, though revenue grew to $821.31 million. Analyst consensus is cautious with 65% hold ratings, and recent news highlights expansion in medical cannabis and new product launches.

The outlook remains challenged by persistent losses and high debt levels, but low valuation ratios like P/S of 0.54 and P/B of 0.35 may attract value investors. Key risks include profitability struggles and regulatory uncertainty, while potential catalysts include international expansion and upcoming earnings on July 28, 2026.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BABA

Alibaba's Qwen AI model to be integrated into Apple services in China, boosting shares 4% premarket.CNBC · 4 hours agoBullish Pomerantz LLP investigates Alibaba over alleged securities fraud and illegal pharmaceutical sales.GlobeNewsWire · 19 hours agoBearish Leveraged ETFs on Alibaba, Meta, Broadcom, and Nvidia surged 17-35% last week amid strong earnings and AI growth.ETF Trends · 23 hours agoBullish View details →

TLRY

Tilray to report Q4 and FY26 financial results on July 28, 2026, with a live webcast call.GlobeNewsWire · 1 day agoNeutral BrewDog Waterloo hosts England's biggest pub watch party for semifinal vs Argentina with £1M bar tab prize.GlobeNewsWire · 2 days agoBullish View details →

About Alibaba Group

Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.